Efficacy and Mechanisms of Mild Therapeutic Hypothermia for Hearing Preservation from NIHL
NIHL 轻度低温治疗对听力保护的疗效和机制
基本信息
- 批准号:10321892
- 负责人:
- 金额:$ 4.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-01-09 至 2022-11-08
- 项目状态:已结题
- 来源:
- 关键词:Acoustic TraumaAcuteAddressAdverse effectsAmericanAnimalsAnti-Inflammatory AgentsAntioxidantsApoptosisApoptoticAttenuatedAuditory Brainstem ResponsesAuditory ThresholdAutopsyBiological ProcessCASP3 geneCaspaseCellsCochleaCochlear NerveControl AnimalDataDevicesEconomic BurdenElementsEngineeringEnvironmentEvaluationExposure toFDA approvedFunctional disorderFutureGenetic TranscriptionHair CellsHearingHearing problemHourImmune responseImmunohistochemistryInflammationInflammation MediatorsInflammatoryInflammatory ResponseInjuryLabyrinthLocationMapsMediatingMilitary PersonnelModelingMolecularMorphologyN-MethylaspartateNervous System TraumaNeuronsNoiseNoise-Induced Hearing LossOccupationalOperative Surgical ProceduresOutcomeOxidative StressPathway AnalysisPathway interactionsPre-Clinical ModelProcessProtocols documentationQuantitative Reverse Transcriptase PCRRattusResidual stateResourcesRodent ModelSafetySensorineural Hearing LossStructureSwellingSynapsesSystemTemperatureTemporary Threshold ShiftTestingTherapeuticTimeTraumaTreatment EfficacyUnited StatesValidationVeteransWorkers&apos Compensationantagonistauditory threshold shiftbaseclinically relevantdesigndisabilityefficacy evaluationefficacy testingexcitotoxicitygene networkhazardhearing impairmenthearing preservationimmunohistochemical markersinnovationinsightmacrophagenatural hypothermianeuroprotectionnoise exposurenormal hearingnovelnovel strategiesotoprotectantpre-clinicalpreclinical studypreservationprotective effectrecruitrectalrelating to nervous systemremote monitoringrepairedreparative processresponse to injuryribbon synapseservice membersoundspiral gangliontranscription factortranscriptometranscriptome sequencing
项目摘要
Project Summary
Noise-induced hearing loss (NIHL) caused by exposure to intense or repeated noise results in damage to the sensitive
structures within the cochlea. NIHL has become one of the leading occupational and recreational hazards afflicting nearly
40 million Americans. NIHL is also a serious concern for our military, and overall results in a high economic burden due
to worker compensation and veteran disability. Although many treatments have been proposed to mitigate NIHL with
promising results in preclinical studies, there are still no FDA-approved treatments for NIHL. Mild therapeutic hypothermia
(30-33 °C) has been extensively studied as a neuroprotective strategy against various types of neurological traumas because
of its ability to mediate various injury responses to trauma including oxidative stress, apoptosis, and inflammation. We aim
to assess the therapeutic benefit of localized therapeutic hypothermia in mitigation of cochlear injury following acoustic
trauma in a rodent model. In this proposal, we seek to engineer a novel non-invasive device used to induce localized mild
therapeutic hypothermia post-NIHL and assess long-term functional hearing and cochlear neural substrate preservation. Our
preliminary results suggest that controlled and localized therapeutic hypothermia provided to the inner ear post-NIHL
significantly lowers hearing threshold shifts in hypothermia-treated animals when compared to normothermic control
animals. Furthermore, we observe reduced cochlear synaptopathology with therapeutic hypothermia. To determine
protective mechanisms underlying hypothermia, we will identify molecular pathways and gene networks that are regulated
by temperature post-NIHL. A detailed characterization of the pathways in a relevant rodent model will provide future
opportunities to identify additional synergistic otoprotective targets. Based on preliminary results, our primary mechanistic
emphases will be on caspase-dependent apoptotic pathways and inflammatory responses with activated macrophage
recruitment and expression. In the long-term, we aim to address the limited therapeutic options for NIHL that may be
extended to various otological traumas, including blast-induced hearing loss or surgically-induced hearing loss.
项目摘要
噪声性听力损失(NIHL)是由于暴露在强烈或反复的噪声中而引起的,会对敏感的大脑造成损害
耳蜗内的结构。NIHL已成为困扰近几年的主要职业和娱乐危害之一
4000万美国人。NIHL也是我们军队的严重关切,总体上造成了沉重的经济负担
工人补偿和退伍军人伤残。尽管已经提出了许多治疗方法来缓解NIHL,
尽管在临床前研究中取得了可喜的结果,但仍没有FDA批准的治疗NIHL的方法。轻度治疗性低温
(30-33°C)作为一种针对各种神经创伤的神经保护策略已被广泛研究,因为
其调节创伤的各种损伤反应的能力,包括氧化应激、细胞凋亡和炎症。我们的目标是
评价局部亚低温治疗对减轻声学耳蜗病的疗效
啮齿动物模型中的创伤。在这项提议中,我们试图设计一种新的非侵入性设备,用于诱导局部轻度
治疗后低温NIHL,并评估长期功能听力和耳蜗神经基质的保存。我们的
初步结果表明,NIHL术后对内耳提供有控制和局部的治疗低温
与常温对照组相比,低温处理的动物显著降低了听力阈值漂移
动物。此外,我们还观察了治疗性低温对耳蜗神经突触病理的影响。要确定
低温下的保护机制,我们将确定受调控的分子通路和基因网络
根据NIHL后的温度。在相关啮齿动物模型中对这些途径的详细描述将提供未来
有机会确定更多的协同耳防目标。根据初步结果,我们的主要机制是
重点将放在caspase依赖的凋亡途径和激活的巨噬细胞的炎症反应上。
招募和表达。从长远来看,我们的目标是解决NIHL有限的治疗选择,可能是
扩大到各种耳科创伤,包括爆炸导致的听力损失或手术导致的听力损失。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Samantha Rincon Sabatino其他文献
Samantha Rincon Sabatino的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Samantha Rincon Sabatino', 18)}}的其他基金
Efficacy and Mechanisms of Mild Therapeutic Hypothermia for Hearing Preservation from NIHL
NIHL 轻度低温治疗对听力保护的疗效和机制
- 批准号:
9911048 - 财政年份:2020
- 资助金额:
$ 4.16万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 4.16万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 4.16万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 4.16万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 4.16万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 4.16万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 4.16万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 4.16万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 4.16万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 4.16万 - 项目类别:
Operating Grants